1160 related articles for article (PubMed ID: 19917954)
41. Basal cell carcinoma and squamous cell carcinoma growth rates and determinants of size in community patients.
Kricker A; Armstrong B; Hansen V; Watson A; Singh-Khaira G; Lecathelinais C; Goumas C; Girgis A
J Am Acad Dermatol; 2014 Mar; 70(3):456-64. PubMed ID: 24373780
[TBL] [Abstract][Full Text] [Related]
42. Diagnostic accuracy in skin cancer clinics: the Australian experience.
Moffatt CR; Green AC; Whiteman DC
Int J Dermatol; 2006 Jun; 45(6):656-60. PubMed ID: 16796621
[TBL] [Abstract][Full Text] [Related]
43. Malignant melanoma and nonmelanoma skin cancers in Northrhine-Westphalia, Germany: a patient- vs. diagnosis-based incidence approach.
Stang A; Ziegler S; Büchner U; Ziegler B; Jöckel KH; Ziegler V
Int J Dermatol; 2007 Jun; 46(6):564-70. PubMed ID: 17550552
[TBL] [Abstract][Full Text] [Related]
44. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003.
Brewster DH; Bhatti LA; Inglis JH; Nairn ER; Doherty VR
Br J Dermatol; 2007 Jun; 156(6):1295-300. PubMed ID: 17535229
[TBL] [Abstract][Full Text] [Related]
45. Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression.
Wang LE; Li C; Strom SS; Goldberg LH; Brewster A; Guo Z; Qiao Y; Clayman GL; Lee JJ; El-Naggar AK; Prieto VG; Duvic M; Lippman SM; Weber RS; Kripke ML; Wei Q
Clin Cancer Res; 2007 Nov; 13(21):6532-9. PubMed ID: 17975167
[TBL] [Abstract][Full Text] [Related]
46. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study.
Lewis KG; Weinstock MA
Arch Dermatol; 2004 Jul; 140(7):837-42. PubMed ID: 15262694
[TBL] [Abstract][Full Text] [Related]
47. Is it really necessary to make wide excisions for basal cell carcinoma treatment?
Unlü RE; Altun S; Kerem M; Koç MN
J Craniofac Surg; 2009 Nov; 20(6):1989-91. PubMed ID: 19881375
[TBL] [Abstract][Full Text] [Related]
48. Predictive value of margins in diagnostic biopsies of nonmelanoma skin cancers.
Jackson JE; Kelly B; Petitt M; Uchida T; Wagner RF
J Am Acad Dermatol; 2012 Jul; 67(1):122-7. PubMed ID: 22088427
[TBL] [Abstract][Full Text] [Related]
49. Efficacy of narrow-margin excision of well-demarcated primary facial basal cell carcinomas.
Kimyai-Asadi A; Alam M; Goldberg LH; Peterson SR; Silapunt S; Jih MH
J Am Acad Dermatol; 2005 Sep; 53(3):464-8. PubMed ID: 16112354
[TBL] [Abstract][Full Text] [Related]
50. Cost effectiveness of Mohs micrographic surgery: review of the literature.
Tierney EP; Hanke CW
J Drugs Dermatol; 2009 Oct; 8(10):914-22. PubMed ID: 19852120
[TBL] [Abstract][Full Text] [Related]
51. 3D histology-guided surgery for basal cell carcinoma and squamous cell carcinoma: recurrence rates and clinical outcome.
Häfner HM; Breuninger H; Moehrle M; Trilling B; Krimmel M
Int J Oral Maxillofac Surg; 2011 Sep; 40(9):943-8. PubMed ID: 21600736
[TBL] [Abstract][Full Text] [Related]
52. Serum carotenoids and alpha-tocopherol and risk of nonmelanoma skin cancer.
Dorgan JF; Boakye NA; Fears TR; Schleicher RL; Helsel W; Anderson C; Robinson J; Guin JD; Lessin S; Ratnasinghe LD; Tangrea JA
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1276-82. PubMed ID: 15298946
[TBL] [Abstract][Full Text] [Related]
53. Mohs' micrographic surgery for treatment of basal cell carcinoma of the face--results of a retrospective study and review of the literature.
Smeets NW; Kuijpers DI; Nelemans P; Ostertag JU; Verhaegh ME; Krekels GA; Neumann HA
Br J Dermatol; 2004 Jul; 151(1):141-7. PubMed ID: 15270883
[TBL] [Abstract][Full Text] [Related]
54. The incidence of incomplete excision in surgically treated basal cell carcinoma: a retrospective clinical audit.
Hussain M; Earley MJ
Ir Med J; 2003 Jan; 96(1):18-20. PubMed ID: 12617437
[TBL] [Abstract][Full Text] [Related]
55. Retrospective analysis of basal cell carcinoma.
Hakverdi S; Balci DD; Dogramaci CA; Toprak S; Yaldiz M
Indian J Dermatol Venereol Leprol; 2011; 77(2):251. PubMed ID: 21393972
[TBL] [Abstract][Full Text] [Related]
56. Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 years.
Leibovitch I; Huilgol SC; Selva D; Richards S; Paver R
J Am Acad Dermatol; 2005 Sep; 53(3):445-51. PubMed ID: 16112351
[TBL] [Abstract][Full Text] [Related]
57. Incidence of residual nonmelanoma skin cancer in excisions after shave biopsy.
Grelck K; Sukal S; Rosen L; Suciu GP
Dermatol Surg; 2013 Mar; 39(3 Pt 1):374-80. PubMed ID: 23279620
[TBL] [Abstract][Full Text] [Related]
58. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis.
Bialy TL; Whalen J; Veledar E; Lafreniere D; Spiro J; Chartier T; Chen SC
Arch Dermatol; 2004 Jun; 140(6):736-42. PubMed ID: 15210467
[TBL] [Abstract][Full Text] [Related]
59. Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery.
Lane JE; Kent DE
Curr Surg; 2005; 62(5):518-26. PubMed ID: 16125611
[TBL] [Abstract][Full Text] [Related]
60. Excising basal cell carcinomas: comparing the performance of general practitioners, hospital skin specialists and other hospital specialists.
Murchie P; Delaney EK; Thompson WD; Lee AJ
Clin Exp Dermatol; 2008 Aug; 33(5):565-71. PubMed ID: 18355357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
